|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 413/14 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3514151 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19160124.4 |
| Date of filing the European patent application | 2015-08-05 | |
| (97) | Date of publication of the European application | 2019-07-24 |
| (45) | Date of publication and mention of the grant of the patent | 2025-04-23 |
| (46) | Date of publication of the claims translation | 2025-07-10 |
| (30) | Number | Date | Country code |
| 201462033679 P | 2014-08-06 | US |
| (72) |
LUZZIO, Michael Joseph , US
PAPILLON, Julien , US
VISSER, Michael Scott , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Proteinkinazės C inhibitoriai ir jų naudojimo būdai |
| PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 11 | 289.00 EUR |
| 2026-08-05 |